Thermo Fisher Scientific (TMO) Research & Development (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Research & Development for 18 consecutive years, with $336.0 million the latest figure, recorded in Q1 2026.

• Research & Development for Q1 2026 came in at $336.0 million, down 1.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 billion (down 0.79% YoY), and the FY2025 annual result was $1.4 billion, up 0.5% from the prior year.
• Research & Development was $336.0 million for Q1 2026 at Thermo Fisher Scientific, down from $356.0 million in the prior quarter.
• Over five years, Research & Development peaked at $391.0 million in Q4 2022 and troughed at $319.0 million in Q3 2023.
• Average Research & Development over 5 years is $348.8 million, with a median of $346.0 million recorded in 2023.
• Year-over-year, Research & Development declined 16.37% in 2023 and gained 14.37% in 2024.
• Over 5 years, Research & Development stood at $391.0 million in 2022, then slipped by 16.37% to $327.0 million in 2023, then increased by 14.37% to $374.0 million in 2024, then dropped by 4.81% to $356.0 million in 2025, then fell by 5.62% to $336.0 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $336.0 million in Q1 2026, $356.0 million in Q4 2025, and $346.0 million in Q3 2025.